AG Pharma Consult SPRL
AG Pharma Consult reported total assets of 50,183 € at the end of the 2025 financial year (annual accounts filed with the NBB on 05 May 2026).
The score of AG Pharma Consult shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -88 % Total assets -58 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
AG Pharma Consult's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 05 May 2026
- Year ended 30 Sep 2024filed on 28 May 2025
- Year ended 30 Sep 2023filed on 13 May 2024
- Year ended 30 Sep 2022filed on 12 May 2023
- Year ended 30 Sep 2021filed on 31 May 2022
AG Pharma Consult's financial analysis
- Solvency20.3%sector median: 56.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of AG Pharma Consult
AG Pharma Consult's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0831.429.560
- VAT number
- BE0831429560
- Peppol
- Registered · 0208:0831429560 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 23 Nov 2010
- Registered office
- 1640 Sint-Genesius-Rode
- Latest accounts
- 2025 · filed on 05 May 2026
- Activity
- Public relations and communication activities (NACE 73300)
AG Pharma Consult (SPRL) has been based in Sint-Genesius-Rode since 2010, active in: public relations and communication activities. For 2025, it reports a net profit of 19,089 € and equity of 10,176 €; its revenue is not published. Its solvency stands at 20.3%, below the median of its sector (56.8%).
Companies similar to AG Pharma Consult
Companies in the same business, of comparable size and area, outside its group.
- Pop2Fly Public relations and communication activities Wezembeek-Oppem · balance sheet 50,153 €
- Mindstructures Public relations and communication activities Duffel · balance sheet 49,902 €
- Xirroh Group Public relations and communication activities Wellen · balance sheet 49,871 €
- NFMC Public relations and communication activities Wezembeek-Oppem · balance sheet 49,720 €
- Chamber's Public relations and communication activities Amay · balance sheet 49,564 €
- WaveXpert Public relations and communication activities Rixensart · balance sheet 51,015 €
- Amasafi Public relations and communication activities Temse · balance sheet 51,072 €
- DARIM Consult Public relations and communication activities Waterloo · balance sheet 51,365 €
Frequently asked questions about AG Pharma Consult
What is the revenue of AG Pharma Consult?
AG Pharma Consult files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of AG Pharma Consult?
In Belgium, the VAT number is the company number prefixed with BE: BE0831429560 for AG Pharma Consult, if the company is VAT-registered. Its company number (CBE) is 0831.429.560.
Where is the registered office of AG Pharma Consult?
According to the CBE register, the registered office of AG Pharma Consult is in 1640 Sint-Genesius-Rode.
What is the equity of AG Pharma Consult?
At the close of the 2025 financial year, the equity of AG Pharma Consult amounts to 10,176 €, a solvency of 20.3% of total assets.
Who manages AG Pharma Consult?
The register lists 2 active mandates at AG Pharma Consult. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of AG Pharma Consult
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →